Sarah Boyce $RNA SEC Form 4 Insider Trading

Sarah Boyce has filed a total of 29 insider trades in $RNA since 2021. Their most recent trade was a sale of 7,993 shares, made on Jan 21, 2026. Their largest trade was a sale of 164,233 shares, made on Jun 13, 2024. We estimate that they now own shares of $RNA, worth an estimated $21.4 million.

Insider Trading at $RNA

There have been a total of 160 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.9 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Michael F Maclean, and Teresa Mccarthy. The most recent trade was a sale of 2,878 shares reported by Steven George Hughes (Chief Medical Officer), made on Jan 21, 2026.

$RNA Executives and Stock Owners with Insider Trades

• Sarah Boyce, President and CEO

• Michael F Maclean, Chief Financial Officer

• Teresa Mccarthy, Chief Human Resources Officer

• Steven George Hughes, Chief Medical Officer

• Arthur A Levin, Chief Scientific Officer

• Kathleen P. Gallagher, Chief Program Officer

• W. Michael Flanagan, CSTO

• W. Michael Flanagan, Chief Scientific Officer

• Eric Mosbrooker, Chief Commercial Officer

• John B Moriarty, Chief Legal Officer

• Charles Iii Calderaro, Chief Technical Officer

• Roderick Wong, MP and CIO

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.